Alan H. Auerbach - Jul 2, 2021 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: PRESIDENT AND CEO, Director, 10%+ Owner
Signature: /s/ Alan H. Auerbach
Stock symbol: PBYI
Transactions as of: Jul 2, 2021
Transactions value $: -$47,121
Form type: 4
Date filed: 7/6/2021, 07:42 PM
Previous filing: Jun 4, 2021
Next filing: Aug 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	COMMON STOCK	Sale	-$47.1K	-5.33K	-0.12%	$8.84	4.42M	Jul 2, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.